Abstract
Amniotic fluid-derived stem (AFS) cells have been described as an appealing source of stem cells because of their (1) fetal, non-embryonic origin, (2) easy access during pregnancy overcoming the ethical issues related both to the use of human embryonic cells and to the postnatal tissue biopsy with donor site morbidity, and (3) their undemanding ability to be expanded. We and others have demonstrated the broad differentiation potential and here we describe the established protocol we developed to obtain c-Kit+ human AFS cells, starting from second trimester amniocentesis samples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dobreva MP, Pereira PN, Deprest J et al (2010) On the origin of amniotic stem cells: of mice and men. Int J Dev Biol 54(5):761–777
Pozzobon M, Ghionzoli M, de Coppi P (2010) ES, iPS, MSC, and AFS cells. Stem cells exploitation for pediatric surgery: current research and perspective. Pediatr Surg Int 26(1):3–10
Prusa AR, Hengstschlager M (2002) Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit 8(11):RA253–RA257
De Coppi P, Bartsch G Jr, Siddiqui MM et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25(1):100–106
De Coppi P, Callegari A, Chiavegato A et al (2007) Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 177(1):369–376
Piccoli M, Franzin C, Bertin E et al (2012) Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model. Stem Cells 30(8):1675–1684
Ditadi A, de Coppi P, Picone O et al (2009) Human and murine amniotic fluid c-Kit+ Lin-cells display hematopoietic activity. Blood 113(17):3953–3960
Cananzi M, Atala A, de Coppi P (2009) Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 18(Suppl 1):17–27
Klein JD, Fauza DO (2011) Amniotic and placental mesenchymal stem cell isolation and culture. Methods Mol Biol 698:75–88
Roubelakis MG, Pappa KI, Bitsika V et al (2007) Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16(6):931–952
Janz Fde L, Debes Ade A, Cavaglieri Rde C et al (2012) Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J Biomed Biotechnol 2012:649353
Kim J, Lee Y, Kim H et al (2007) Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 40(1):75–90
Tsai MS, Hwang SM, Tsai YL et al (2006) Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 74(3):545–551
Abumaree M, Al Jumah M, Pace RA et al (2012) Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 8(2):375–392
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pozzobon, M., Piccoli, M., Schiavo, A.A., Atala, A., De Coppi, P. (2013). Isolation of c-Kit+ Human Amniotic Fluid Stem Cells from Second Trimester. In: Turksen, K. (eds) Stem Cell Niche. Methods in Molecular Biology, vol 1035. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-508-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-62703-508-8_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-507-1
Online ISBN: 978-1-62703-508-8
eBook Packages: Springer Protocols